⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10274078 | 1.00 | — | — | |
| SCHEMBL17920190 | 1.00 | — | — | |
| SCHEMBL15185118 | 1.00 | — | — | |
| SCHEMBL15185117 | 1.00 | — | — | |
| SCHEMBL15832400 | 1.00 | — | — | |
| SCHEMBL22142580 | 1.00 | — | — | |
| SCHEMBL9943073 | 0.82 | — | — | |
| SCHEMBL22141994 | 0.82 | — | — | |
| SCHEMBL22141993 | 0.82 | — | — | |
| SCHEMBL22142219 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023115203-A1 | OXER1 ANTAGONISTS AND USES THEREOF | FAIRHAVEN PHARMACEUTICALS INC. (CA) | 2023-06-29 | — | — | WO | disclosed |
| CN-107848967-B | Cyclic quaternary ammonium salts as fuel or lubricant additives | 因诺斯佩克有限公司 | 2022-05-27 | — | — | CN | disclosed |
| WO-2022040600-A1 | COMPOUNDS AS GLP-1R AGONISTS | TERNS PHARMACEUTICALS, INC. (US) | 2022-02-24 | — | — | WO | disclosed |
| US-11136615-B2 | Compositions and methods for stabilizing benzothiazole luciferin analogs | PROMEGA CORPORATION (US) | 2021-10-05 | — | — | US | disclosed |
| US-10689589-B2 | Cyclic quaternary ammonium salts as fuel or lubricant additives | INNOSPEC LIMITED (GB) | 2020-06-23 | — | — | US | disclosed |
| WO-2020081572-A1 | TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2020-04-23 | — | — | WO | disclosed |
| US-20180223203-A1 | CYCLIC QUATERNARY AMMONIUM SALTS AS FUEL OR LUBRICANT ADDITIVES | INNOSPEC LIMITED (GB) | 2018-08-09 | — | — | US | disclosed |
| CN-107848967-A | As fuel or the cyclic quaternary ammonium salts of lubricant additive | 因诺斯佩克有限公司 | 2018-03-27 | — | — | CN | disclosed |
| US-20170157104-A1 | Anti-Viral Compounds | ABBVIE INC. (US) | 2017-06-08 | — | — | US | disclosed |
| US-20170157105-A1 | Anti-Viral Compounds | ABBVIE INC. (US) | 2017-06-08 | — | — | US | disclosed |
| WO-2009055828-A1 | NEW TETRACYCLIC COMPOUNDS | MEDIVATION TECHNOLOGIES, INC. (US) | 2009-04-30 | — | — | WO | disclosed |
| EP-1902717-A2 | Vasopressin antagonist and oxytocin antagonist | Otsuka Pharmaceutical Company, Limited (JP) | 2008-03-26 | — | — | EP | disclosed |
| EP-0620003-B1 | VASOPRESSIN ANTAGONIST AND OXYTOCIN ANTAGONIST | OTSUKA PHARMA CO LTD (JP) | 2008-01-16 | — | — | EP | disclosed |
| US-7157487-B2 | Vla-4 inhibitors | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2007-01-02 | — | — | US | disclosed |
| US-5753644-A | Vasopressin antagonist and oxytocin antagonist | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1998-05-19 | — | — | US | disclosed |
| US-5622947-A | VASODILATORS, HYPOTENSIVE AGENTS, DIURETICS, PLATELET AGGLUTINATION INHIBITORS; ALSO USED TO PREVENT PREMATURE BIRTH, TREAT DYSMENORRHEA | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-04-22 | — | — | US | disclosed |
| EP-0620003-A1 | VASOPRESSIN ANTAGONIST AND OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-10-19 | — | — | EP | disclosed |
| US-4599343-A | Perfluoroindolizines and emulsions thereof useful as blood substitutes | THE GREEN CROSS CORPORATION (JP) | 1986-07-08 | — | — | US | disclosed |
| US-4596810-A | Synthetic blood | THE GREEN CROSS CORPORATION (JP) | 1986-06-24 | — | — | US | disclosed |
| US-4591599-A | Perfluoropyrrolizines and emulsions thereof useful as blood substitutes | THE GREEN CROSS CORPORATION (JP) | 1986-05-27 | — | — | US | disclosed |